Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$499,491
-$82,972 QoQ
Shares Held
20,743
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,756
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAHL & GAYNOR INC holds $1,357,498,569 across 6 Drug Manufacturers - General names. PFE ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
656,123 | $786,973,675 | |
| 2 | JNJ |
Johnson & Johnson
|
1,970,876 | $500,543,377 | |
| 3 | AMGN |
Amgen Inc
|
186,593 | $67,569,057 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
28,240 | $1,627,188 | |
| 5 | PFE |
Pfizer Inc
This page
|
20,743 | $499,491 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,262 | $285,781 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $499,491 | 20,743 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $582,463 | 20,743 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $633,530 | 25,443 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $749,239 | 29,405 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $778,200 | 32,104 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,068,587 | 42,170 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,272,962 | 47,982 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,924,625 | 66,504 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,954,710 | 69,861 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,079,723 | 74,945 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,360,520 | 81,991 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,324,164 | 100,216 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $4,123,418 | 112,416 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,574,128 | 112,111 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,197,273 | 120,946 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,484,134 | 125,323 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,467,764 | 123,360 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,361,186 | 122,874 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,279,684 | 123,280 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,324,551 | 123,798 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,112,455 | 130,553 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,869,855 | 134,415 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $25,364,114 | 689,055 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $26,415,935 | 719,781 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $23,950,060 | 732,417 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $96,735,754 | 2,963,722 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||